Kerr Douglas 4
4 · Dyne Therapeutics, Inc. · Filed Dec 6, 2024
Insider Transaction Report
Form 4
Kerr Douglas
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2024-12-04+76,600→ 76,600 totalExercise: $29.44Exp: 2034-12-03→ Common Stock (76,600 underlying) - Award
Common Stock
2024-12-04+48,000→ 95,500 total
Footnotes (3)
- [F1]Consists of shares of Common Stock issuable under 48,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 4, 2025.
- [F2]Includes 95,500 unvested RSUs.
- [F3]This option was granted on December 4, 2024. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 4, 2028.